ODI Pharma schedules annual general meeting for December
ODI Pharma AB has announced its annual general meeting will take place in Stockholm on December 4, 2026. Shareholders must register by November 30 to attend.
ODI Pharma AB has issued a formal notice for its annual general meeting (AGM), scheduled for December 4, 2026, at 14:00 CET. The event will be held at the company’s headquarters at Östermalmstorg 1 in Stockholm, providing a forum for shareholders to exercise their voting rights on key corporate governance matters.
To be eligible to attend, shareholders must be registered in the share register maintained by Euroclear Sweden AB no later than November 26, 2026. Furthermore, participants are required to notify the company of their attendance via email by November 30, 2026.
During the registration process, attendees must provide their full name and personal or corporate identification details. The meeting serves as the primary mechanism for shareholders to review the company’s performance and vote on board appointments and financial reports for the fiscal period.